
Amit X. Garg
Articles
-
Jan 14, 2025 |
medium.datadriveninvestor.com | Amit X. Garg
Tau Ventures recently invested in Kerna Labs, a Bay Area biotech startup innovating in the field of mRNA therapeutics. Founded in 2024, Kerna Labs is focused on enhancing mRNA therapeutics through AI powered design. Here’s why Kerna Labs represents a transformative opportunity in the biotech sector:Kerna Labs stands out for its focus on using foundation models of RNA to find mRNA sequences with vastly improved half-life, translatability, tissue-specificity and manufacturability.
-
Nov 20, 2024 |
jamanetwork.com | Amit X. Garg |Meaghan S. Cuerden |Jessica M. Sontrop |Jennifer Arnold
Hypertension and Kidney Function After Living Kidney Donation Amit X. Garg, MD, PhD; Jennifer B. Arnold, BSc; Meaghan S. Cuerden, PhD; Christine Dipchand, MD; Liane S. Feldman, MD; John S. Gill, MD; Martin Karpinski, MD; Scott Klarenbach, MD; Greg Knoll, MD; Charmaine E. Lok, MD; Matthew Miller, MD; Mauricio Monroy-Cuadros, MD; Christopher Nguan, MD; G. V. Ramesh Prasad, MD; Jessica M.
-
Aug 20, 2024 |
medium.datadriveninvestor.com | Amit X. Garg
In Dec 2019 I published an article “15 Years Of Trying To Be Carbon-Neutral: Practical Uses Of Technology For Individuals.” That article’s focus was to tie three specific projects my wife and I had implemented over the years to larger developments, in the hopes they sparked practical insights for others: 1) Transportation — traded our cars for more fuel-efficient ones 2) Energy — invested in one set of solar panels and then added to it 3) Water — series of water-saving measures including...
-
Jul 27, 2024 |
medium.datadriveninvestor.com | Amit X. Garg
Excited to be investing in the $3.5M seed of ShiftRx alongside Workbench Ventures and Inflect Health. Tau Ventures is an AI-first fund in Silicon Valley investing primarily in mature seed, typically when there is a pipeline of customers. ShiftRx is a platform leveraging AI to solve for the labor shortage in the healthcare industry. Their work is focused on automating the administrative backend tasks such as sourcing, onboarding, credentialing, scheduling, and billing for healthcare providers.
-
Jun 12, 2024 |
jamanetwork.com | Andrew Strunk |Amit X. Garg |George Han
Key PointsQuestion What is the overall prevalence of lichen planopilaris (LPP), and what treatments are patients with LPP receiving? Findings In this cross-sectional study, the standardized overall prevalence of LPP was 13.4 per 100 000. Most of the 991 patients with LPP received topical/intralesional corticosteroids or systemic medications, and a substantial number were treated for more than 1 year, required combination treatment, and underwent treatment switching.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →